Drawing for Serial No. 79426527

USPTO serial 79426527

Serial No. 79426527

Reviewed by CopyMark Law Group

Reg. 8073003Status 700Registered
Filing date
Status date
Registration date
Dec 23, 2025
Examiner
PEISECKI, MARK A
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79426527?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthmaACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 23, 2026FINVFINAL DECISION TRANSACTION PROCESSED BY IB
Jul 4, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB
Jul 4, 2026FIMPFINAL DISPOSITION PROCESSED
Mar 23, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 23, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 23, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 4, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 4, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 29, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 10, 2025RFNTREFUSAL PROCESSED BY IB
Oct 7, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 2, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Oct 2, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 2, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 29, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 29, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 29, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 29, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 29, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 29, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 24, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 24, 2025RFRRREFUSAL PROCESSED BY MPU
Aug 12, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 11, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 2, 2025DOCKASSIGNED TO EXAMINER
Jul 11, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Jul 11, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 30, 2025LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 26, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance